液体活检在肿瘤监测管理中的应用(4)
[12]Gandara DR，Paul SM.Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab[J].Nat Med，2018，24(9)：1441-1448.[13]Büttner R，Longshore JW，López-Ríos F ......
您现在查看是摘要页，全文长 2093 字符。